Many people have called it quit dreaming of accomplishing the seemingly impossible because they felt they only have few years to live. This mind-set does no good to these individuals as well as the entire human race. Development and advancement in all areas of life will suffer if more and more elderly people who still have a lot to give our world hold this perception. All their years of experience will amount to a waste. There is need to make them understand that they can live longer, not in an attempt to deceive them into putting in their best efforts to better the lots of humans but because life-extension is already a possibility. The likes of Mikhail Blagosklonny must be appreciated for making longevity a reality and for spreading this good news across the globe. You may want to know this exceptional personality. Follow Mikhail on Google Scholar
Mikhail Blagosklonny is at the moment a Professor of Oncology at Roswell Park Cancer Institute. He had previously worked with the New York Medical College and Ordway Research Institute as Associate Professor and Senior Scientist respectively. Blagosklonny is a product of First Pavlov State Medical University of St. Peterburg where he obtained a MD in Internal Medicine and a PhD in Experimental Medicine and Cardiology.
Blagosklonny discovered aging to be a process which if slowed will extend the life span of the average human being. It took him years of studies and researches to arrive at this conclusion. He singled out rapmycin as one drug that can help achieve this feat for just anybody. Rapmycin is widely known to retard the growth of tumor; this ability was sighted by Blagosklonny as capable of doing same to the aging process thereby leading to longevity.
Spreading the good news that longetivity is now a possibility is as important as the discovery of the drug behind it. Mikhail Blagosklonny had to bring to bear his writing skills authoring several books and articles to disseminate the good news. He also made his editorial acumen available to a number of medical journals and magazines for the same purpose. The likes of Oncotarget, Cell Cycle and Aging, among many other medical journals, have him as their editor-in-chief.
Longevity or anti-aging is sure to make our world better by rewarding industrious elderly people with extended life span, but we have to appreciate the likes of Mikhail Blagosklonny for championing this noble course. Visit classroomvoices.org to read more about Mikhail.